Could Johnson & Johnson’s $5.5bn talc deal finally close a 15-year legal overhang?
Johnson & Johnson proposes a $5.5 billion deal for 76,000 ovarian talc claims, but participation, future lawsuits and costs remain critical.
Johnson & Johnson proposes a $5.5 billion deal for 76,000 ovarian talc claims, but participation, future lawsuits and costs remain critical.
See why Fujifilm’s new endoscopy warehouse could strengthen service capacity, device uptime and U.S. hospital growth. Read the full analysis.